KLRK1 and glioblastoma: Therefore, to determine the mechanism of EGFR signaling pathway regulation of NK cells in GBM, further studies are needed to focus on whether GBM with EGFR alterations express higher levels of NKG2D ligands or which form of the ligands are expressed in EGFR-altered GBM.